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Abstract: The Cub Sushi Multiple Domains-1 (CSMD1) protein is a tumour suppressor which has
been shown to play a role in regulating human mammary duct development in vitro. CSMD1
knockdown in vitro demonstrated increased cell proliferation, invasion and motility. However, the
role of Csmd1 in vivo is poorly characterised when it comes to ductal development and is therefore an
area which warrants further exploration. In this study a Csmd1 knockout (KO) mouse model was used
to identify the role of Csmd1 in regulating mammary gland development during puberty. Changes
in duct development and protein expression patterns were analysed by immunohistochemistry. This
study identified increased ductal development during the early stages of puberty in the KO mice,
characterised by increased ductal area and terminal end bud number at 6 weeks. Furthermore,
increased expression of various proteins (Stat1, Fak, Akt, Slug/Snail and Progesterone receptor)
was shown at 4 weeks in the KO mice, followed by lower expression levels from 6 weeks in the KO
mice compared to the wild type mice. This study identifies a novel role for Csmd1 in mammary
gland development, with Csmd1 KO causing significantly more rapid mammary gland development,
suggesting an earlier adult mammary gland formation.
Keywords: Csmd1; mammary gland development; epithelial mesenchymal transition; terminal end
bud; extracellular matrix; Fak; Stat1; Akt
1. Introduction
The CUB Sushi Multiple Domains-1 (CSMD1) gene is located in the chromosome
region 8p23 spanning a 2MB region of DNA and this encodes multiple transcripts for the
CSMD1 gene in humans. The largest and most common form of the transcripts is 14,552
base pairs long and consists of 71 exons [1]. In total there are 17 splice variants of the
CSMD1 gene [2]. The largest of these variants encodes a 3565 amino acid protein which
has a molecular mass of 383kDa in humans. The Csmd1 mouse protein demonstrates
93% homology to the human orthologue [1]. The CSMD1 protein primarily consists of 14
CUB domains and 14 sushi domains; these domains alternate so that each CUB domain
is separated by a sushi domain, with a section of 14 sushi domains leading to the C-
terminus [1]. The CUB (Complement C1r/C1s, Uegf, BMP1) domain is 110 residues in size
and found in a range of extracellular and membrane bound proteins, with these proteins
commonly having roles in developmental patterning and complement regulation [3–5].
The sushi domain, also known as the complement control protein domain, is 66 residues in
size and is commonly associated with proteins involved in complement regulation or cell
adhesion proteins [6–8]. The Csmd1 protein is located in the cell membrane, leading it to
be determined as a transmembrane protein with a large N-terminal extracellular region
and a short internal 66 amino acid cytoplasmic tail at the C-terminus which contains a
putative tyrosine phosphorylation site [1]. CSMD1 has been shown to be expressed in both
neuronal and epithelial tissues, with high levels of CSMD1 identified in the breast, testis
and kidneys in humans and mice.
CSMD1 has been characterised, using a range of in vivo and in vitro approaches, and
is implicated in various processes, such as testicular development, complement regulation,
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schizophrenia and in cancer progression [9–13]. In relation to cancer, CSMD1 has been
identified as a tumour suppressor with previous studies identifying the chromosome
location 8p23 as an area deleted in various cancers, such as breast, head and neck and
colorectal [1,12–19]. Furthermore CSMD1 deletion has also been linked to poor prognosis
in patients with late stage breast cancer [12,17,20,21]. Recently, the role of Csmd1 in
developmental processes was examined, with Csmd1 knockout (KO) in mice leading to
reduced fertility through altered regulation of spermatozoa production [11]. There have
also been studies examining the role of Csmd1 and duct development. These studies
show that pregnant mice have increased ductal growth when Csmd1 is knocked out and
in-vitro ductal studies identify more rapid cell growth and duct formation in CSMD1
KO cells [11,22]. These studies, along with further characterisation studies of CSMD1,
have identified that the deletion of CSMD1 causes increased cell invasion, motility and
proliferation [14,15,22,23]. These studies therefore suggest a potential role for CSMD1 in
the regulation of epithelial mesenchymal transition (EMT). EMT is the process by which
functional epithelial cells are able to revert back to a stem cell state, which allows the
cells to become more proliferative and migratory [24–26]. Furthering the connection
between Csmd1 and EMT showed a connection between Csmd1 and Nf-κß, a well-known
EMT factor, where Csmd1 inhibition leads to increased Nf-κß activity and increased EMT
phenotype in gastric cancer [14,27]. Along with changes in Nf-κß signalling, alterations
in Smad signalling have also been identified to be associated with changes in Csmd1
expression [13,15,28]. Csmd1 has also been implicated in the regulation of complement,
where it primarily regulates the formation of the C3 convertase [7,10,11,29]. Recently Csmd1
KO has been shown to promote C3 deposition on the synapses promoting synaptic pruning
in mice [29].
The mammary gland is responsible for producing milk, which is then required for the
raising of new-borns as it provides them with all the nutrients required for development.
Therefore the understanding of how the mammary gland develops is very important, as
any abnormalities in mammary gland development will lead to malnourished and poorly
developed new-borns. In mice the mammary gland undergoes most of its development
during puberty between 4–8 weeks of age, with the gland being fully formed by 12 weeks
of age (Figure 1A). During mammary gland development, the formation of the ductal tree is
driven by structures called terminal end buds (TEBs) [30,31]. TEBs are highly proliferative
structures at the ends of the ducts which promote ductal growth into the mammary fat
pad leading to the formation of the ductal tree (Figure 1B). Csmd1 has been shown to be
involved in the regulation of the ductal development in an in-vitro model [22]. This showed
that CSMD1 KO in MCF-10A cells is able to determine dysregulated ductal development
by promoting increased cell proliferation, invasion and motility [22]. These characteristics
were also shown in other in-vitro studies in breast cancer cell lines in which high levels of
CSMD1 expression demonstrate slower motility and also decreased invasive properties
compared to cell lines with none or inhibited CSMD1 expression [15,22].
Although some studies have briefly examined the role of Csmd1 in ductal develop-
ment and also during pregnancy, currently no studies have fully explored the role of Csmd1
during mammary gland development. Consequently, this study used a Csmd1 KO mouse
model to examine the development of the mammary gland during puberty into adulthood,
with the additional aim of identifying potential mechanisms of action for Csmd1. In this
study specific protein expression patterns were analysed to determine changes Csmd1 KO
has on their expression. Proteins were selected primarily due to their connection to EMT
regulation, a mechanism which Csmd1 has previously been suggested to be involved in
regulating [14,15,22,23]. A range of proteins were analysed in order to narrow down the
specific EMT pathway Csmd1 regulates.
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Figure 1. (A) Schematic of mammary gland development over the course of puberty (B) Terminal
End Bud (TEB) structure, identifying the structure and types of cells present.
2. Materials and Methods
2.1. Mouse Model
The B6;129S5-Csmd1tm1Lex/Mmucd mouse strain (Csmd1 KO) mouse was created
by Lexicon Pharmaceuticals through deletion of a 1 kb genomic sequence composed of
part of exon 1 and intron 1 caused by insertion of a LacZ/Neo cassette [32]. This Csmd1
KO model generates a whole mouse knockout for Csmd1, including the spliced forms of
Csmd1. Csmd1 KO cryopreserved mouse embryos were first implanted into healthy wild
type female (WT) mice (C57BL/6). This then created a F1 generation of heterozygotes,
which were used to breed the F2 generation which has all 3 mouse types, with the F2
WT and KO mice being used to create the F3 generation of mice (Figure A1). New-born
mice were then genotyped at 3 weeks of age by ear notch to identify which mice were WT,
Csmd1 KO or heterozygous mice. The F3 generation of female mice were then harvested at
the required time points 4, 6, 8 and 12 weeks of age. At 4 weeks 14 WT and 14 KO mice;
6 weeks 9 WT and 11 KO mice; 8 weeks 7 WT and 8 KO mice; 12 weeks 7 WT and 9 KO
mice were collected. The sample sizes were determined using the power analysis statistical
test. All procedures were approved by the UK Home Office and carried out according to
the Animals (Scientific Procedures) Act 1986.
2.2. Whole Mount Staining
The abdominal mammary glands were exercised from the female mice, with one gland
being used for whole mount staining and the other embedded in paraffin to be used for
staining. The gland used for the whole mount was fixed in 4% PFA overnight at room
temperature (RT) (20 ◦C). The mammary gland was then rehydrated using decreasing
concentrations of ethanol (100%, 70%, 50%) and dH2O. Following the rehydration the gland
was submerged in carmine alum solution overnight at RT to stain the ducts in the mammary
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gland. After staining, the ducts were then dehydrated in increasing concentrations of
ethanol (50%, 70%, 100%) and washed in xylene solution to remove any excess staining
from the mammary gland, leaving only the ducts with visible staining. The glands were
then mounted using a glycerol based mounting agent and were viewed and imaged at x4
objective using bright field capture on a Nikon Eclipse Ti-E microscope, this was to observe
and count the TEBs. Images of the whole stained mammary gland were taken using a Sony
digital SLR camera to obtain the area of the ductal tree.
2.3. Haematoxylin and Eosin (H&E) Staining
The mammary gland sections to be used for staining were initially fixed in 4% PFA
overnight before being fixed in paraffin and then sectioned using a microtome at 5 µm.
These sections were then used for the H&E, Picro-Sirus Red and IHC stains. For the H&E
stain the sections were dewaxed using xylene before being rehydrated using a decreasing
ethanol concentration before being submerged in Haematoxylin solution, followed by
Eosin solution. After the staining with the two solutions, the sections were dehydrated
using increasing ethanol concentrations and xylene. The sections were then mounted using
DPX (Merek).
2.4. Picro-Sirus Red Staining
The sections were dewaxed and rehydrated as previously stated. The slides were then
submerged in Wiegerts haematoxylin (Sigma) for 20 min to stain the nuclei. The slides were
then stained using Picro-Sirus Red solution for 1 h, after which the slides were washed
in tap water and left to dry for 30 min. Finally, the slides were dehydrated using 100%
ethanol and then xylene, and then mounted using DPX.
2.5. Immunohistochemistry (IHC)
IHC was performed to analyse the expression of Mcm2, Stat1, Fak, Slug/Snail and
Akt (Abcam) and progesterone receptor (Thermo Fisher). The paraffin embedded sections
of mammary gland were stained using the primary antibodies following a previously
described protocol using the conditions described in Table 1 [17]. Following the primary
antibody incubation, staining was detected with Novolink polymer (Leica Biosystems)
according to the manufacturer’s protocol. The sections were developed using diaminoben-
zidine (DAB) (Leica Biosystems) to visualise the areas of positive expression. Antibody
free negative controls were used along with the use of tissues known to express the specific
proteins as positive controls (Figure A2).
Table 1. Antibodies used in this study. Table shows the host species, target area of the protein which
the antibody binds and the IHC conditions including stock dilution and the antigen retrieval times
(performed in pH6 citrate buffer unless stated).
Antibody





Mcm2 (ab4461) Rabbit Aa 1–50 1:100 (2 min)
PR (RM-9102-s0) Rabbit Aa 412–526 1:400 (2 min)
Stat1 (ab47425) Rabbit Aa 694–743 1:300 (3 min)
Fak (ab40794) Rabbit Aa 700–800 1:100 (4 min)
Slug/Snail
(ab180714) Rabbit Aa 236–264 1:200 (2 min)
Akt (ab179463) Rabbit Aa 250 to C terminus 1:200 (2 min, pH 9citrate buffer)
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2.6. Quantification and Statistical Analysis
The quantification analysis for the Roundness and Picro-Sirus Red stains were per-
formed using image J software. The Picro-Sirus Red stain used a threshold analysis
to obtain the amount of collagen present around each duct, with each image being
scaled to ensure all of the collagen had been selected for analysis. Roundness equa-
tion: 4 × area/(π x major_axisˆ2) (Image J manual). The analysis for the IHC markers
used QuPath Software [33]. For this a script was created which was able to differentiate
between cells with no/low levels of expression of the protein in question and those with
high levels of expression, this would then provide the number of positive cells compared
to the number of negative cells. This was performed for both nuclear and cytoplasmic
expressing proteins. All p-values were obtained using the student’s t-test. Statistical tests
p < 0.05 were considered significant.
3. Results
3.1. Csmd1 KO Leads to Increased Mammary Gland Development during Early Stages of Puberty
To explore the changes of Csmd1 KO on mammary gland development, initially the
size of the mammary glands of each female mouse was measured. Male mice were not
analysed in this mammary gland study due to the fact that they only develop a rudimentary
ductal structure in which any changes caused by Csmd1 KO may be difficult to be detected.
This identified increased mammary gland sizes in both at 4 weeks (p < 0.05) and 6 weeks
(p < 0.001) of age in the KO mice (Figure 2A). However, subsequently there were no
significant changes in mammary gland size in either the 8 or 12 week old mice, which had
similar sized mammary glands in the KO mice and the WT mice (Figure 2A). Next we
explored whether the ductal tree itself shows signs of increased growth. Interestingly, the
ductal trees at 4 weeks of age were of a similar size in both the KO and WT mice, despite
the increased mammary gland size observed (Figure 2B,C). The ductal tree did show a
significant increase in size in the 6 week old KO mice (p < 0.05), with the ductal area being
slightly larger at 8 weeks in the KO mice, but not significantly so, and then the ductal area
was a similar size at 12 weeks in both the KO and WT mice (Figure 2C).
To further understand what could be causing the increased ductal area observed, the
number of TEBs was analysed. This is due to the role TEBs play in driving duct invasion
and development into the mammary gland fat pad [30]. This identified similar levels of
TEB numbers at 4, 8 and 12 weeks of age in the KO and WT mice (Figure 3A,B). However,
at 6 weeks of age the number of TEBs identified in each gland was significantly increased
(p < 0.05) in the KO mice compared to the WT mice (Figure 3B).
This therefore shows that in Csmd1 KO mice the deficiency of Csmd1 is able to drive
increased ductal development at an early stage of puberty (6 weeks). This is demonstrated
by increased mammary gland size and ductal area, but also through increased TEB number
at this time point.
3.2. Csmd1 KO is Able to Generate Changes in Ductal Morphology, along with Altering
Mammary Gland Development Factors
Next, any changes at the cellular level during development, along with any changes
in regulatory growth patterns, were explored. The morphology of the ducts was analysed
to identify changes to the structure of the ducts in the KO mice, to see if they show
dysregulated developmental patterns. This was analysed by measuring the roundness of
the ducts. Healthy/normal ducts tend to have round/circular ducts with dysregulated
ducts producing non-uniform shapes and therefore less rounded ducts. In this study the
Csmd1 KO mice demonstrated a decrease in roundness of ducts at 6 weeks (p < 0.001) and
12 weeks (p < 0.01), with a slight decrease in roundness observed at 8 weeks (Figure 4A).
This therefore indicates that the ducts are undergoing altered ductal morphological changes
in the KO mice, leading to irregular development of the ducts. Here the KO mice have
a higher number of ducts with irregular shapes, which leads to the decrease in duct
roundness observed, whereas in the WT mice there are very few irregular ducts.
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Figure 2. Loss of Csmd1 leads to increased mammary gland size and ductal growth. (A) Graph 
showing the changes in mammary gland size between the WT and Csmd1 KO mice. The area of 
the abdominal fat pad was measured in each mouse (mm2), showing significant changes at 4 and 6 
week (* p < 0.05 and *** p < 0.001). The numbers of animals for each time point included 4-week-
old mice (n = 12: WT; n = 14 KO), 6-week-old mice (n = 5: WT; n = 11 KO), 8-week-old mice (n = 7: 
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Figure 2. Loss of Csmd1 leads to increased mammary gland size and ductal growth. (A) Graph showing the changes in
mammary gland size between the WT and Csmd1 KO mice. The area of the abdominal fat pad was measured in each mouse
(mm2), showing significant changes at 4 and 6 week (* p < 0.05 and *** p < 0.001). The numbers of animals for each time
point included 4-week-old mice (n = 12: WT; n = 14 KO), 6-week-old mice ( = 5: WT; n = 11 KO), 8-week-old mice (n = 7:
WT; n = 8 KO), 12-week-old mice (n = 7: WT; n = 9 KO). (B) Whole mount stained mammary glands at all ages (4, 6, 8,
12 weeks) from both WT and KO mice, scale bar 10 mm. The images show the ductal trees within the mammary gland fat
pad. (C) Graph showing the differences in ductal tree area between the WT and KO mice, (m 2), with significant differences
noted at 6 weeks (* p < 0.05). The numbers of animals for each time point included 4-week-old mice (n = 12: WT; n = 10 KO),
6-week-old mice (n = 5: WT; n = 10 KO), 8-week-old mice (n = 7: WT; n = 7 KO), 12-week-old mice (n = 7: WT; n = 7 KO).
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Figure 3. Csmd1 KO leads to increased terminal end bud number during duct development. (A) Images of the whole
mount stained mammary glands taken at x4 objective. The terminal end buds are identified in the images by the white
arrows and the scale is 100 µm. (B) Graph depicting the changes in terminal end bud number between the WT and KO
mice, changes were observed at 6 weeks of age (* p < 0.05). The numbers of animals for each time point included 4-week-old
mice (n = 12: WT; n = 10 KO), 6-week-old mice (n = 5: WT; n = 10 KO), 8-week-old mice (n = 7: WT; n = 7 KO), 12-week-old
mice (n = 7: WT; n = 7 KO).
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Figure 4. Loss of Csmd1 is able to promote changes in ductal morphology and development factors. (A) Graph showing
changes in duct roundness, the lumen of the ducts were measured and t en analys d using ImageJ software. The roundness
rating is between 0 and 1, with 1 being a perfect circle (** p < 0.01 and *** p < 0.001). The numbers of animals for each
time point included 4-week-old mice (n = 6 WT; n = 6 KO), 6-week-old mice (n = 8 WT; n = 7 KO), 8-week-old mice (n = 7
WT; n = 7 KO), 12-week-old mice (n = 7 WT; n = 7 KO). (B) Analysis of the Picro-Sirus Red staining, which is used to stain
collagen red. The staining is shown in the images below the graph which depicts ducts at 6 weeks of age in the WT and KO
mice, with the red collagen staining located around each duct. The graph shows the percentage of collagen surrounding
each duct, which was calculated using ImageJ (* p < 0.05) (n = 6 WT; n = 6 KO), 6-week-old mice (n = 8 WT; n = 7 KO),
8-week-old mice (n = 7 WT; n = 7 KO), 12-week-old mice (n = 7 WT; n = 7 KO) (C) The analysis of progesterone receptor (PR)
expression, the images show respective examples of the ducts at each time point in both the WT and KO mice. The graph
highlights the percentage of cells which positively express PR (** p < 0.01 and *** p < 0.001). The numbers of animals for
each time point included (n = 6 WT; n = 6 KO), 6-week-old mice (n = 8 WT; n = 7 KO), 8-week-old mice (n = 7 WT; n = 7 KO),
12-week-old mice (n = 7 WT; n = 7 KO). (D) Analysis of the level of proliferation occurring in each duct in the WT and KO
mice. The images show proliferation in the ducts at all ages in both the WT and KO mice, with the graph showing number
of cells actively proliferating (*** p < 0.001). The numbers of animals for each time point included 4-week-old mice (n = 6
WT; n = 6 KO), 6-week-old mice (n = 8 WT; n = 7 KO), 8-week-old mice (n = 7 WT; n = 7 KO), 12-week-old mice (n = 7 WT;
n = 7 KO). All images taken using an x40 objective, with all scale bars 100 µm.
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Potential changes in factors which effect mammary gland development were also
analysed, which included collagen levels, progesterone receptor (PR) expression and
proliferation. Collagen was analysed due its role in regulating duct development, and
also that it is the most commonly expressed protein within the ECM [34]. The amount
of collagen surrounding each duct remained at similar levels at 4, 8 and 12 weeks of age
between the KO and WT mice (Figure 4B). However, there was a significantly higher
level of collagen deposition around each duct at 6 weeks of age (p < 0.05) (Figure 4B).
The expression of PR was also analysed since it plays an important role in promoting
ductal invasion into the mammary fat pad [35,36]. The KO mice demonstrated significant
changes in PR expression at all of the analysed time points. At 4 weeks the KO mice had
significantly higher levels of PR expression (p < 0.01) compared to the WT mice (Figure 4C).
Interestingly, from 6 weeks onwards, the KO mice expressed significantly lower levels of
PR than the WT mice (p < 0.001 (6/12 weeks) and p < 0.01 (8 weeks)) (Figure 4C). When
exploring if there were any changes in the number of proliferating cells, it was noticed
that a similar expression to that of PR was observed. This meant that there were a higher
number of proliferating cells at 4 weeks of age, although in this instance the increase
observed did not reach statistical significance (Figure 4D). Then from 6 weeks onwards
there was a significant decrease in the number of proliferating cells at each time point
(p < 0.001) (Figure 4D).
These changes further consolidate that there is a significant change occurring during
the early stages of mammary gland development (4–6 weeks).
3.3. Csmd1 KO Leads to the Altered Expression Patterns of Mammary Gland Development
Associated Proteins
To explore potential mechanisms of action in which Csmd1 could be involved in
regulation, the expression patterns of various proteins connected with mammary gland
development were analysed.
One of the proteins analysed was the signal transducer and activator of transcription
1 protein (Stat1), which has been shown to have high levels of expression during early and
peak puberty, with these levels then decreasing as the mice reach adulthood [37,38]. In this
study higher levels of Stat1 expression were identified at 4 weeks in the KO mice, although
this was not a significant increase (Figure 5A). However, from 6 weeks onwards at all time
points, statistically significantly lower levels of Stat1 expression were observed in the KO
mice compared to the WT mice (p < 0.001) (Figure 5B). Interestingly, it was also observed
that in the WT mice the peak expression for Stat1 was observed at 6 weeks of age, but in
the KO mice the highest level of Stat1 expression was noticed at 4 weeks (Figure 5B). There
was also a similar pattern observed in the PR expression analysis (Figure 4C).
The changes observed in the ducts ability to infiltrate the mammary fat pad suggests
an increase in the invasive properties of the cells in the Csmd1 KO mice. An important
mechanism regulating cell invasion is cell adhesion mediated signalling, consequently
the expression of cell adhesion regulating molecules were analysed. These were the focal
adhesion kinase (Fak) [39,40] and Slug/Snail signalling [41]. The expression pattern of Fak
seemed to show a very similar pattern of expression to that of Stat1, in that at 4 weeks there
is a non-significant increase in Fak expression in the KO mice (Figure 6A,B). Followed by
a statistically significant decrease in expression at all time points from 6 weeks onwards
(p < 0.001) (Figure 6B). The highest peaks in expression were observed at 4 weeks in
the KO mice and 6 weeks in the WT mice. Both the levels of cytoplasmic and nuclear
Slug/Snail expression were measured, revealing a statistically significant higher level
of nuclear expression in the KO mice at both 4 and 6 weeks of age (p < 0.001), which
then significantly decrease at 8 weeks (p < 0.001) before the Slug/Snail expression levels
become similar to the WT in the adult mice (Figure 6C–E). A slightly different pattern
of Slug/Snail cytoplasmic expression was observed with similar levels of expression at
4 weeks of age before Slug/Snail expression is significantly increased at 6 weeks of age in
the KO mice (p < 0.001) (Figure 6C,D). This was followed by significantly lower Slug/Snail
cytoplasmic expression in the KO at 8 weeks (p < 0.001), before having similar levels of
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expression at 12 weeks in the KO and WT mice (Figure 6D). Slug/Snail displays a different
expression pattern compared to most of the other proteins analysed, as it seems to have
higher Slug/Snail expression at 4 weeks (in the nucleus) in the KO mice which is the same
as other proteins analysed, but it also has higher levels of expression at 6 weeks in the
KO (Figure 6E). This 6-week change shows an alternative expression pattern for the KO
mice. Furthermore the WT expression pattern is also different for Slug/Snail expression as
there is no clear observable peak of expression at 6 weeks, instead the expression levels of
Slug/Snail remain similar between 4–8 weeks before decreasing at 12 weeks (Figure 6D,E).
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Figure 5. Changes in Stat1 expression are generated by Csmd1 KO. (A) Images showing the expression
of Stat1 within the mammary glands ducts at all time points in both the WT and KO mice, stained
using IHC (B) Graph highlighting the average percentage of cells positively expressing Stat1 between
the WT and KO ducts by counting the percentage of positive cells per duct (*** p < 0.001). The
numbers of animals for each time point included (n = 6 WT; n = 6 KO), 6-week-old mice (n = 8 WT;
n = 7 KO), 8-week-old mice (n = 7 WT; n = 7 KO), 12-week-old mice (n = 7 WT; n = 7 KO). All images
were taken using an x40 objective, with all scale bars 100 µm.
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Figure 6. Csmd1 KO causes changes in the expression of cell adhesion associated proteins. (A) Images of Fak expression
within the ducts of the mammary gland at all ages in both the WT and KO mice. (B) Graph highlighting the changes in Fak
expression in each duct at the various ages between the WT and KO mice, with the average expression of Fak per duct
being shown (*** p < 0.001). The numbers of animals for each time point (n = 6 WT; n = 6 KO), 6-week-old mice (n = 8 WT;
n = 7 KO), 8-week-old mice (n = 7 WT; n = 7 KO), 12-week-old mice (n = 7 WT; n = 7 KO) (C) Images of Slug and Snail
expression within the ducts of the mammary glands at all ages in both the WT and KO mice. (D) Graph highlighting the
changes in cytoplasmic levels of Slug and Snail expression at the various ages between the WT and KO mice, with the
average expression of Slug and Snail per duct being shown (*** p < 0.001). (E) Graph highlighting the changes in nuclear
Slug and Snail expression at the various ages between the WT and KO mice, with the average expression of Fak per duct
being shown (*** p < 0.001). The numbers of animals for each time point included (n = 6 WT; n = 6 KO), 6-week-old mice
(n = 8 WT; n = 7 KO), 8-week-old mice (n = 7 WT; n = 7 KO), 12-week-old mice (n = 7 WT; n = 7 KO). All images were taken
using an x40 objective, with all scale bars 100 µm.
Finally, the expression of the Pi3k/Akt signalling cascade was analysed by measuring
the levels of Akt. This signalling pathway was chosen because it is commonly upregulated
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in cells and cancers, which are undergoing EMT [42–44]. In the case of the Akt expression,
it showed higher levels of expression at 4 weeks in the KO mice, although this was not a
significant increase. However, there was statistically significantly less Akt expression in
the KO from 6 weeks onwards (p < 0.001) (Figure 7A,B). In contrast to the other proteins
analysed there was not a decrease in Akt expression between 4 and 6 weeks of age, as the
expression levels remained similar. Instead, the Akt in the KO mice appeared to decrease
from 8 weeks (Figure 7B). However, in the WT mice the Akt expression pattern was similar
to the patterns previously observed in other proteins, in that it has a noticeable high peak
of expression at 6 weeks of age.
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Figure 7. Loss of Csmd1 causing changes in the expression patterns of Pi3k/Akt signaling. (A,B)
Akt expression analysis. (A) Images showing the amount of positive Akt expression in the mammary
gland ducts at all ages in the WT and KO mice, using IHC staining. (B) The graph shows the average
percentage of cells which are positively expressing Akt in each duct (*** p < 0.001). The numbers of
animals for each time point included (n = 6 WT; n = 6 KO), 6-week-old mice (n = 8 WT; n = 7 KO),
8-week-old mice (n = 7 WT; n = 7 KO), 12-week-old mice ( = 7 WT; n = 7 KO). All images were taken
using an x40 objective, with all scale bars 100 µm.
In the WT mice there is a clear pattern of expression for the majority of proteins,
which have their highest level of expression at 6 weeks of age (Figure 8A,B). This therefore
highlights that in the WT mice, the time at which the mice are undergoing the largest
developmental changes is at 6 weeks, suggesting that this is the peak of puberty in these
mice. However in the KO mice this peak in protein expression appears to occur earlier
than 6 weeks, with the highest expression levels in the KO mice being at 4 weeks of age.
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In addition after 6 weeks (Fak, Mcm2, PR, Stat1 and Slug/Snail) or 8 weeks (Akt) in the
KO mice there appears to be a large decease in protein levels in the majority of proteins
analysed compared to the WT expression levels.




Figure 8. The expression patterns of the proteins analysed show alternative peaks of expression in 
the Csmd1 KO mice compared to the WT. The expression levels across all time points (4–12 weeks) 
are shown to demonstrate how the specific expression of the proteins changes over puberty and 
also how the patterns vary between the WT and KO mice. (A) Graph showing the proteins associ-
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Figure 8. The ex sion patterns of the proteins analysed show alternativ peaks of expression in
the Csmd1 KO mice compared to the WT. The expression levels across all time points (4–12 weeks) are
shown to demonstrate how th specific expression of the proteins changes over puberty and also how
the patterns vary between the WT and KO mice. (A) Graph showing the proteins associated with
regulating cell adhesion. (B) Graph showing the proteins associated with regulating cell proliferation.
In both graphs clear alternative peaks can be observed between the WT, peak of expression commonly
at 6 weeks, and the KO mice, peak of expression commonly at 4 weeks.
4. Discussion
The effects of Csmd1 KO have been well characterised in vitro, with a role for Csmd1
in duct development being identified [13–15,22,23] but there have been very few studies
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exploring the role of Csmd1 in development in vivo [11,14]. Therefore there is a need to
expand and confirm the observations seen in vitro in an in vivo environment. In this study
the role of Csmd1 in mammary gland development has been explored for the first time in a
Csmd1 KO mouse model.
Throughout this study the Csmd1 KO mice showed a number of changes during
the early stages of female mammary gland development (4–6 weeks). This was initially
demonstrated when examining the gross structural changes in the development of the
ductal tree, which showed increased mammary gland size and ductal tree area at 6 weeks
of age in the KO mice. In addition, this increase in duct development was supported by the
observed increase in TEBs at 6 weeks in the KO mice. This therefore suggests that the Csmd1
KO is able promote a more invasive and expansive ductal tree, with the process being driven
by the increased TEB number. This increase in TEB number therefore highlights a potential
role for Csmd1 in the regulation of cell proliferation and invasion mechanisms, which
have previously been identified [22,23]. This connection is strengthened with changes
in proliferation, ECM deposition and in Akt signalling observed in the KO mice [42,45].
Most notably, the higher levels of proliferation and Akt signalling at 4 weeks, followed
by the decrease at 6 weeks in the KO mice, which suggests that the earlier high levels of
proliferation observed could be able to generate the larger numbers of TEBs observed at
6 weeks in the KO. Potentially, the higher levels of proliferation could be driven by an
increase in Akt mediated signalling. Hence the regulation of Akt mediated signalling by
Csmd1 could explain the increased action and number of TEBs present. This will then
promote a more invasive phenotype allowing for increased fat pad infiltration [46,47].
There were also observed changes in the structure of the ducts in the KO mice, which
appeared to lead to dysregulated ductal structure. This dysregulated structure could be
caused by a number of factors. Firstly if the level of proliferation is increased from an early
age, which was shown in the 4 week KO mice, it could cause the ducts to development
more rapidly [46], therefore preventing normal ductal formation and also generating
higher numbers of cells, leading to abnormal duct shapes. Furthermore, the increase in
proliferation might be a driving mechanism behind the increased TEB number. Secondly,
another mechanism behind the changes in duct morphology could be related to alterations
in cell polarity [48]. Changes in cell polarity are able to effect lumenogenesis and therefore
if this is dysregulated in the KO mice, then the lumens of the ducts will be unable to form,
therefore producing the dysregulated duct formation [48]. Any potential changes in cell
polarity can be regulated by tight junction function [49], therefore conferring a connection
to cell adhesion and invasion mechanisms.
Other factors which are able to promote ductal development are changes in hormone
regulation and ECM deposition [34,36]. In this study significant changes were observed
between the KO and WT mice in both these factors during the early stages of puberty. The
levels of PR are shown to be significantly increased at 4 weeks in the KO mice but then were
significantly lower from this point onwards. The ECM appears to only show a significant
increase in collagen deposition at 6 weeks of age in the KO mice. The increased level of
PR expression per duct suggests increased susceptibility to progesterone in the Csmd1 KO
mice from an early age. This increased level of progesterone mediated action could then
be a factor behind increased TEB numbers observed at 6 weeks. This is due to the fact
that PR and progesterone action plays a prominent role in promoting TEBs [30,36,50,51].
Interestingly it has been shown that in normal (WT) mice PR expression appears to peak
between 6–7 weeks of age, however in our Csmd1 KO mice this peak appears to occurring
noticeably earlier at 4 weeks [36]. This further highlights the potential of Csmd1 KO mice
undergoing more rapid duct development. The increase in ECM deposition observed at
6 weeks is likely to be a by-product of the increased duct development. However it could
also be involved in promoting the increased duct development in the KO mice. This is
because when higher levels of ECM deposits are noticed it is usually is an identifying
factor of a stiffer ECM matrix. This stiffer matrix is able to promote cell-ECM interactions
which in turn promotes cell invasion and duct elongation, consequently the increased
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ECM deposition could also promote the increased ductal growth observed [34,52]. This
study demonstrates that Csmd1 KO causes changes in both hormone regulation and ECM
deposition, with these changes leading to a more invasive ductal phenotype [34,53]. The
link between reduced CSMD1 expression and a more invasive ductal phenotype is also
supported by human breast cancer studies, in which reduced CSMD1 expression was
associated with reduced differentiation and increased tumour grade [17].
Due to changes observed in duct invasion and ECM levels we wanted to identify a
specific mechanism of action that could be being promoted/causing these changes. One
such mechanism is cell adhesion signalling which has been shown to be involved in
interacting with the microenvironment to regulate cell invasion [54]. For this reason the
cell adhesion regulator proteins Fak [55] and Slug/Snail [56] were analysed to see if this
is a potential mechanism of action for Csmd1. Both of these proteins showed increased
expression levels at 4 weeks in the KO mice, with the Fak expression becoming lower than
the WT levels from 6 weeks. However the levels of Slug/Snail remained higher at 6 weeks
in the KO and then reduced to levels lower than the WT from 8 weeks. This suggests that
Csmd1 KO could cause changes in cell adhesion regulation. The potential impact of these
changes is that the duct cells in the KO mice are able to generate an increased number of
cell-ECM interactions, via increased focal adhesion action [57–59]. Since the changes in Fak
and Akt expression are similar, this suggests that increased Fak mediated signalling of Akt
pathways is occurring in the Csmd1 KO mice [60–62]. In which this signalling cascade then
promotes increased cell migration and invasion in the KO mice, via the increased action of
focal adhesions [60–62].
The expression patterns of Stat1 was determined in this study to corroborate the
earlier mammary gland development observed in the Csmd1 KO mice. Stat1 is an excellent
marker for mammary gland development stage because Stat1 demonstrates its highest
levels of expression at the beginning of puberty when development of the mammary
gland is at its highest, with the levels decreasing into adulthood [37,38]. Consequently
by analysing the levels of Stat1 expression it’s possible to determine when the mammary
gland is undergoing peak puberty. In this study in the WT mice the peak Stat1 expression
is at 6 weeks of age, but in the Csmd1 KO mice this peak is at 4 weeks of age. This provides
rather compelling evidence that the mammary glands in the KO mice are likely to be
undergoing more rapid mammary gland development. This concept is supported by
changes in expression patterns of the other markers analysed in the study (Mcm2, PR, Fak),
they all demonstrate the peak of expression in the WT mice at 6 weeks of age. However
in the KO mice the majority of the markers have the highest expression at 4 weeks of age.
This would suggest that as the KO mice have higher expression levels of protein expression
from an earlier age (4 weeks) they are able to drive the phenotypical changes observed at
6 weeks. Consequently a fully formed ductal tree is observed at 8 weeks of age in the KO
mice as there is no change in ductal tree size between 8–12 weeks, whereas in the WT mice
this fully formed ductal tree appears at 12 weeks.
5. Conclusions
In summary, this study explores for the first time the role of Csmd1 in the process
of mammary gland development, leading on from previous in-vitro ductal models [22].
Increased ductal development from an early age was identified in the Csmd1 KO mice and
that this development occurs more rapidly leading to the earlier generation of an adult
duct. The changes identified throughout this study identify a strong connection between
Csmd1 and the regulation of cell invasiveness, which is potentially controlled via changes
in cell adhesion mechanisms. Since Csmd1 is a known tumour suppressor gene it would
be interesting to explore the role of Csmd1 in cancer in vivo, to determine if the in-vitro
changes observed in this study are also involved in regulating cancer development.
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Figure A1. Information regarding the breeding structure used to generate the mouse cohort used
in this study (A), along with a PCR gel electrophoresis image showing how the mice genotypes
were identified (B). To generate the mouse the cohort initially a Csmd1 KO mouse embryos were
implanted into a pregnant WT mouse, this generated the F1 gen ration consisti g f both WT and KO
mice. These wer then breed wit further WT mice (C57BL/6). This generated an F2 generation
consisting f either heter zygotes (H ts) or WT mic . The Hets were then breed with each other to
generate both KO and WT mice. The KO mice were then further breed with each other to obtain the
full KO cohort, with mice being harvested at 4, 6, 8 and 12 weeks. The WT mice breed throughout
this study were also harvested at the same time points.
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Figure A2. Image showing examples of the negative and positive controls used in this study. The
negative control was an antibody free control to determine any background staining caused by the
kit used. The positive control was performed on tissue known to express the protein in question.
These tests were performed on the same tissue types for each run performed, with this tissue being
full adult, >16 weeks of age, wild type mammary glands.
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